Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.42 Trillion Total Companies: 1,736
Total Market Cap (USD)
$1.42 Trillion
Companies Listed
1,736
Largest Company
Aldeyra The
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 751 |
Aldeyra The
NASDAQ:ALDX |
$67.56 Million | $67.56 Million | USA | $1.42 | +14.52% | -71.66% | 98.02 Million |
| 752 |
ReproCELL Incorporated
F:6RC |
$67.55 Million | €65.81 Million | Germany | €0.72 | -2.04% | -4.64% | 21.00K |
| 753 |
Alterity Therapeutics Ltd
NASDAQ:ATHE |
$67.51 Million | $67.51 Million | USA | $3.50 | +4.78% | -3.32% | 232.80K |
| 754 |
MOLECULAR PARTNERS ADS/1
F:6ML0 |
$67.50 Million | €65.76 Million | Germany | €3.76 | +5.03% | -9.62% | 50.80K |
| 755 |
Hyloris Developmentsen Sa
BR:HYL |
$66.67 Million | €64.95 Million | Belgium | €5.80 | -2.68% | -12.39% | 145.57K |
| 756 |
Frequency Therapeutics Inc
NASDAQ:KRRO |
$66.19 Million | $66.19 Million | USA | $11.41 | -7.31% | -0.61% | 5.56 Million |
| 757 |
Apex Biotechnology Corp
TW:1733 |
$65.42 Million | NT$2.16 Billion | Taiwan | NT$29.50 | +0.00% | +3.51% | 4.23 Million |
| 758 |
Arch Biopartners Inc
OTCQB:ACHFF |
$65.25 Million | $65.25 Million | USA | $1.27 | -0.55% | +0.00% | 20.40K |
| 759 |
Pliant Therapeutics Inc
NASDAQ:PLRX |
$65.08 Million | $65.08 Million | USA | $1.28 | -3.76% | -7.91% | 14.96 Million |
| 760 |
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ:NTHI |
$64.92 Million | $64.92 Million | USA | $8.11 | -8.47% | -13.91% | 952.40K |
| 761 |
AADI BIOSCIENCES DL-0001
F:3350 |
$64.26 Million | €62.60 Million | Germany | €3.30 | +0.61% | -8.84% | 0.00 |
| 762 |
GlycoNex
TWO:4168 |
$64.08 Million | NT$2.12 Billion | Taiwan | NT$23.90 | -1.24% | -4.59% | 7.57 Million |
| 763 |
Pyxis Oncology Inc
NASDAQ:PYXS |
$63.17 Million | $63.17 Million | USA | $1.53 | -5.56% | -1.29% | 7.84 Million |
| 764 |
Actinogen Medical Limited
PINK:ATGGF |
$63.06 Million | $63.06 Million | USA | $0.03 | +0.00% | +0.00% | 0.00 |
| 765 |
CANBRIDGE PHARM.DL-00001
F:MF1 |
$62.87 Million | €61.24 Million | Germany | €0.21 | +2.94% | -1.87% | 1.53 Million |
| 766 |
ViGenCell Inc.
KQ:308080 |
$62.81 Million | ₩91.97 Billion | Korea | ₩5710.00 | -2.06% | -0.35% | 31.17 Million |
| 767 |
Adagene Inc
NASDAQ:ADAG |
$62.71 Million | $62.71 Million | USA | $3.94 | +0.77% | +34.47% | 4.99 Million |
| 768 |
Leap Therapeutics Inc
NASDAQ:LPTX |
$62.33 Million | $62.33 Million | USA | $2.05 | +368.57% | +391.14% | 817.45 Million |
| 769 |
Equillium Inc
NASDAQ:EQ |
$61.85 Million | $61.85 Million | USA | $2.13 | -0.93% | +8.12% | 13.43 Million |
| 770 |
Cartesian Therapeutics Inc.
NASDAQ:RNAC |
$61.76 Million | $61.76 Million | USA | $6.65 | -7.38% | -22.22% | 6.36 Million |
| 771 |
Poolbeg Pharma PLC
PINK:POLBF |
$61.33 Million | $61.33 Million | USA | $0.12 | +0.00% | +0.00% | 0.00 |
| 772 |
Seres Therapeutics Inc
NASDAQ:MCRB |
$60.99 Million | $60.99 Million | USA | $9.03 | -3.78% | +0.89% | 2.17 Million |
| 773 |
Panacea Biotec Limited
NSE:PANACEABIO |
$60.69 Million | ₹5.26 Billion | India | ₹340.95 | +7.49% | -3.62% | 2.63 Million |
| 774 |
Repare Therapeutics Inc
NASDAQ:RPTX |
$60.59 Million | $60.59 Million | USA | $2.65 | +0.76% | +2.71% | 37.69 Million |
| 775 |
BIOCELTIX S.A. ZY -10
F:XI3 |
$60.17 Million | €58.61 Million | Germany | €15.30 | +1.19% | -4.14% | 220.00 |
| 776 |
Transgene SA
PINK:TRGNF |
$59.90 Million | $59.90 Million | USA | $0.70 | +0.00% | -55.97% | 400.00 |
| 777 |
Jiangsu Recbio Technology Co., Ltd.
F:G93 |
$59.81 Million | €58.27 Million | Germany | €0.46 | +8.49% | +9.00% | 167.39K |
| 778 |
MediciNova Inc
NASDAQ:MNOV |
$59.35 Million | $59.35 Million | USA | $1.41 | -4.08% | +0.00% | 1.53 Million |
| 779 |
NanoCarrier Co. Ltd
F:3NQ |
$58.74 Million | €57.22 Million | Germany | €0.88 | -2.76% | -2.76% | 3.91K |
| 780 |
Jade Biosciences, Inc.
NASDAQ:JBIO |
$58.11 Million | $58.11 Million | USA | $13.78 | -1.36% | -4.83% | 7.38 Million |
| 781 |
CTCBIO Inc
KQ:060590 |
$58.02 Million | ₩84.95 Billion | Korea | ₩3980.00 | -0.87% | -0.62% | 2.53 Million |
| 782 |
PLIANT THERA.INC.DL-0001
F:9PT |
$57.71 Million | €56.23 Million | Germany | €1.14 | +2.70% | -1.72% | 11.53K |
| 783 |
Mereo BioPharma Group plc
F:MAH0 |
$57.50 Million | €56.01 Million | Germany | €0.32 | -5.64% | +0.63% | 78.60K |
| 784 |
e-therapeutics plc
PINK:ETXPF |
$57.33 Million | $57.33 Million | USA | $0.13 | +0.00% | +0.00% | 0.00 |
| 785 |
OSE Pharma SA
PA:OSE |
$57.23 Million | €55.75 Million | France | €3.51 | -2.07% | -13.73% | 2.45 Million |
| 786 |
Gwo Xi Stem Cell Applied Technology Co. , Ltd
TWO:6704 |
$57.05 Million | NT$1.89 Billion | Taiwan | NT$23.00 | +0.00% | -2.54% | 2.60 Million |
| 787 |
OSE IMMUNOTHERAPE.EO -20
F:6OP |
$56.93 Million | €55.47 Million | Germany | €3.49 | -4.18% | -12.19% | 10.00K |
| 788 |
KNOTUS Co.Ltd
KQ:278650 |
$56.64 Million | ₩82.93 Billion | Korea | ₩1256.00 | +1.21% | +2.61% | 7.96 Million |
| 789 |
GREEN CROSS WellBeing Corporation
KQ:234690 |
$56.60 Million | ₩82.88 Billion | Korea | ₩9900.00 | +8.79% | +8.67% | 4.27 Million |
| 790 |
Sagittarius Life Science
TWO:3205 |
$56.40 Million | NT$1.87 Billion | Taiwan | NT$50.70 | -0.39% | -2.50% | 3.27 Million |
| 791 |
Surrozen Inc
NASDAQ:SRZN |
$55.31 Million | $55.31 Million | USA | $25.68 | +0.31% | -7.43% | 1.83 Million |
| 792 |
BeyondSpring Inc
NASDAQ:BYSI |
$54.91 Million | $54.91 Million | USA | $1.79 | +0.00% | +21.77% | 571.41K |
| 793 |
1S90
F:1S90 |
$54.21 Million | €52.81 Million | Germany | €7.82 | +4.83% | +2.36% | 1.83K |
| 794 |
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD |
$54.18 Million | $54.18 Million | USA | $4.88 | -8.44% | -15.72% | 9.90 Million |
| 795 |
Frontage Holdings Corporation
PINK:FGHQF |
$53.77 Million | $53.77 Million | USA | $0.10 | +0.00% | +0.00% | 0.00 |
| 796 |
3D Global Biotech Inc.
TWO:6808 |
$53.67 Million | NT$1.78 Billion | Taiwan | NT$34.00 | -5.03% | -13.15% | 4.00 Million |
| 797 |
iBio, Inc. Common Stock
NASDAQ:IBIO |
$53.60 Million | $53.60 Million | USA | $2.19 | -10.98% | -7.98% | 24.35 Million |
| 798 |
Nanoform Finland Plc
HE:NANOFH |
$53.44 Million | €52.06 Million | Finland | €0.66 | +8.20% | -1.64% | 5.52 Million |
| 799 |
Cingulate Inc
NASDAQ:CING |
$53.20 Million | $53.20 Million | USA | $8.04 | -31.05% | +2.16% | 12.98 Million |
| 800 |
GeneOne Life Science Inc
KO:011000 |
$52.94 Million | ₩77.51 Billion | Korea | ₩1066.00 | -1.57% | -3.00% | 43.27 Million |
| 801 |
UnicoCell Biomed Co., Ltd.
TW:6794 |
$52.57 Million | NT$1.74 Billion | Taiwan | NT$80.70 | +0.88% | -1.59% | 2.06 Million |
| 802 |
TuHURA Biosciences Inc
NASDAQ:HURA |
$52.08 Million | $52.08 Million | USA | $1.88 | -9.62% | +4.44% | 27.07 Million |
| 803 |
Kronos Bio Inc
NASDAQ:KRON |
$51.83 Million | $51.83 Million | USA | $0.88 | +1.49% | +0.89% | 30.71 Million |
| 804 |
JW (Cayman) Therapeutics Co. Ltd
PINK:JWCTF |
$51.68 Million | $51.68 Million | USA | $0.16 | +0.00% | +0.00% | 0.00 |
| 805 |
Sensorion SA
PA:ALSEN |
$51.24 Million | €49.92 Million | France | €0.58 | -12.65% | +23.14% | 103.32 Million |
| 806 |
Prelude Therapeutics Inc
NASDAQ:PRLD |
$51.17 Million | $51.17 Million | USA | $3.12 | -9.04% | -13.33% | 7.73 Million |
| 807 |
Nordic Nanovector ASA
F:8NN |
$50.85 Million | €49.54 Million | Germany | €0.42 | +5.36% | +12.37% | 16.79K |
| 808 |
Sunny Pharmtech Inc.
TWO:6676 |
$50.47 Million | NT$1.67 Billion | Taiwan | NT$15.70 | +0.32% | -7.92% | 6.93 Million |
| 809 |
Thor Medical ASA
OL:TRMED |
$50.43 Million | Nkr574.55 Million | Norway | Nkr4.90 | +3.59% | +12.39% | 69.41 Million |
| 810 |
Tscan Therapeutics Inc
NASDAQ:TCRX |
$50.42 Million | $50.42 Million | USA | $1.07 | -1.83% | -9.32% | 14.20 Million |
| 811 |
NANOFORM FINLAND OYJ
F:4YL |
$50.12 Million | €48.83 Million | Germany | €0.62 | -0.80% | -10.42% | 141.87K |
| 812 |
InflaRx N.V.
NASDAQ:IFRX |
$50.11 Million | $50.11 Million | USA | $0.88 | -3.64% | -5.38% | 5.00 Million |
| 813 |
G&E Herbal Biotechnology Co., Ltd.
TWO:4911 |
$49.69 Million | NT$1.64 Billion | Taiwan | NT$34.55 | +0.14% | +0.73% | 1.40 Million |
| 814 |
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS |
$49.53 Million | $49.53 Million | USA | $0.44 | -3.11% | -8.51% | 57.06 Million |
| 815 |
METXF
PINK:METXF |
$49.53 Million | $49.53 Million | USA | $2.95 | +0.00% | +0.00% | 0.00 |
| 816 |
Vytrus Biotech S.A.
MC:VYT |
$49.38 Million | €48.11 Million | Spain | €13.00 | +4.84% | +14.04% | 258.28K |
| 817 |
SynAct Pharma AB
ST:SYNACT |
$49.17 Million | Skr551.59 Million | Sweden | Skr17.32 | -2.59% | -5.87% | 4.95 Million |
| 818 |
PolyPid
NASDAQ:PYPD |
$49.01 Million | $49.01 Million | USA | $4.39 | -3.73% | +1.62% | 1.13 Million |
| 819 |
Infant Bacterial Therapeutics AB (publ)
ST:IBT-B |
$48.72 Million | Skr546.59 Million | Sweden | Skr49.35 | +0.71% | -3.05% | 113.28K |
| 820 |
Oncopeptides AB (publ)
PINK:ONPPF |
$48.58 Million | $48.58 Million | USA | $0.27 | +0.00% | +0.00% | 0.00 |
| 821 |
ImageneBio, Inc.
NASDAQ:IMA |
$48.40 Million | $48.40 Million | USA | $5.83 | -3.24% | -4.04% | 771.63K |
| 822 |
Bluebird bio Inc
NASDAQ:BLUE |
$48.34 Million | $48.34 Million | USA | $4.97 | +0.00% | +0.00% | 21.53 Million |
| 823 |
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS |
$48.24 Million | $48.24 Million | USA | $1.79 | -0.56% | -26.64% | 8.92 Million |
| 824 |
Bio-FD&C Co. Ltd.
KQ:251120 |
$48.18 Million | ₩70.55 Billion | Korea | ₩13870.00 | -0.07% | -1.28% | 725.45K |
| 825 |
MAIA Biotechnology Inc.
NYSE MKT:MAIA |
$47.90 Million | $47.90 Million | USA | $1.49 | -0.67% | -0.67% | 27.83 Million |
| 826 |
Adicet Bio Inc
NASDAQ:ACET |
$47.35 Million | $47.35 Million | USA | $6.93 | -3.62% | -7.97% | 3.34 Million |
| 827 |
Coeptis Therapeutics Inc
NASDAQ:COEP |
$46.70 Million | $46.70 Million | USA | $11.11 | -5.04% | -12.00% | 1.02 Million |
| 828 |
Flerie
ST:FLERIE |
$46.64 Million | Skr523.21 Million | Sweden | Skr35.10 | +0.29% | -2.77% | 940.56K |
| 829 |
Abliva AB
ST:ABLI |
$46.60 Million | Skr522.79 Million | Sweden | Skr0.44 | +0.00% | +0.00% | 565.71K |
| 830 |
Raphas Co. Ltd
KQ:214260 |
$46.56 Million | ₩68.18 Billion | Korea | ₩10320.00 | -1.62% | +0.98% | 854.60K |
| 831 |
TaiRx, Inc.
TWO:6580 |
$45.99 Million | NT$1.52 Billion | Taiwan | NT$15.55 | -6.89% | -12.64% | 4.00 Million |
| 832 |
Inhibikase Therapeutics Inc
NASDAQ:IKT |
$45.69 Million | $45.69 Million | USA | $1.83 | -6.63% | -6.15% | 31.03 Million |
| 833 |
ANPAC BIO-MED SP.ADS/20 A
F:0UC0 |
$45.32 Million | €44.15 Million | Germany | €18.00 | +0.00% | +0.00% | 0.00 |
| 834 |
Sinew Pharma Inc.
TWO:6634 |
$45.30 Million | NT$1.50 Billion | Taiwan | NT$33.25 | -0.15% | -6.47% | 980.41K |
| 835 |
SYN-Tech Chem & Pharm Co Ltd
TWO:1777 |
$45.13 Million | NT$1.49 Billion | Taiwan | NT$72.20 | +0.28% | +0.98% | 794.39K |
| 836 |
Impact BioMedical, Inc.
NYSE MKT:IBO |
$45.11 Million | $45.11 Million | USA | $0.44 | +0.07% | +4.89% | 5.09 Million |
| 837 |
CORESTEM Inc
KQ:166480 |
$44.37 Million | ₩64.97 Billion | Korea | ₩2635.00 | -3.48% | -0.57% | 16.83 Million |
| 838 |
Valerio Therapeutics
PA:ALVIO |
$43.68 Million | €42.55 Million | France | €0.11 | -18.94% | -24.38% | 4.82 Million |
| 839 |
Bioton S.A.
WAR:BIO |
$43.32 Million | zł180.12 Million | Poland | zł4.18 | +2.20% | +0.72% | 843.09K |
| 840 |
Intech Biopharm Ltd
TWO:6461 |
$43.25 Million | NT$1.43 Billion | Taiwan | NT$19.40 | -0.51% | -6.51% | 15.56 Million |
| 841 |
Adlai Nortye Ltd.
F:N2U0 |
$43.18 Million | €42.07 Million | Germany | €6.35 | +3.25% | -9.29% | 2.21K |
| 842 |
XBiotech Inc
NASDAQ:XBIT |
$42.96 Million | $42.96 Million | USA | $2.25 | +0.00% | -3.43% | 654.63K |
| 843 |
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762 |
$42.95 Million | NT$1.42 Billion | Taiwan | NT$30.00 | +4.90% | +11.52% | 5.38 Million |
| 844 |
KoBioLabs Inc
KQ:348150 |
$42.88 Million | ₩62.78 Billion | Korea | ₩4625.00 | -1.18% | +2.21% | 2.34 Million |
| 845 |
Annovis Bio Inc
NYSE:ANVS |
$42.15 Million | $42.15 Million | USA | $2.47 | -9.85% | -4.26% | 8.61 Million |
| 846 |
Medicenna Therapeutics Corp
OTCQX:MDNAF |
$42.11 Million | $42.11 Million | USA | $0.64 | -2.29% | -9.36% | 527.60K |
| 847 |
Entera Bio Ltd
NASDAQ:ENTX |
$42.05 Million | $42.05 Million | USA | $1.34 | -2.90% | -10.07% | 2.39 Million |
| 848 |
Sol Gel Technologies Ltd
NASDAQ:SLGL |
$41.43 Million | $41.43 Million | USA | $75.34 | -5.53% | -11.35% | 622.76K |
| 849 |
BIOTON S.A. ZY 20
F:7U5 |
$41.40 Million | €40.33 Million | Germany | €0.94 | +0.21% | +0.65% | 7.05K |
| 850 |
Lite Strategy, Inc.
NASDAQ:LITS |
$41.20 Million | $41.20 Million | USA | $1.18 | -2.48% | +0.85% | 7.07 Million |
| 851 |
Aileron Therapeutics Inc
NASDAQ:ALRN |
$40.98 Million | $40.98 Million | USA | $2.11 | +0.00% | +0.00% | 63.39K |
| 852 |
OS Therapies Incorporated
NYSE MKT:OSTX |
$40.59 Million | $40.59 Million | USA | $1.51 | -1.31% | -7.36% | 10.55 Million |
| 853 |
Vivani Medical Inc.
NASDAQ:VANI |
$40.09 Million | $40.09 Million | USA | $1.17 | -3.31% | +0.00% | 4.95 Million |
| 854 |
Arovella Therapeutics Ltd
AU:ALA |
$39.76 Million | AU$64.22 Million | Australia | AU$0.07 | +0.00% | -5.96% | 16.08 Million |
| 855 |
Grace Therapeutics, Inc.
NASDAQ:GRCE |
$39.63 Million | $39.63 Million | USA | $4.44 | -0.22% | +12.41% | 8.23 Million |
| 856 |
Onxeo SA
F:C4X |
$39.59 Million | €38.57 Million | Germany | €0.10 | -20.49% | -26.24% | 8.87K |
| 857 |
NRX Pharmaceuticals Inc
NASDAQ:NRXP |
$39.37 Million | $39.37 Million | USA | $1.90 | -2.56% | +4.97% | 14.73 Million |
| 858 |
Immutep Ltd
AU:IMM |
$39.35 Million | AU$63.55 Million | Australia | AU$0.05 | +1.96% | -85.35% | 875.28 Million |
| 859 |
Radiopharm Theranostics Limited American Depositary Shares
PINK:RADX |
$39.26 Million | $39.26 Million | USA | $4.71 | -9.25% | -15.14% | 371.90K |
| 860 |
Metagenomi, Inc. Common Stock
NASDAQ:MGX |
$39.24 Million | $39.24 Million | USA | $1.44 | -1.37% | -18.18% | 5.58 Million |
| 861 |
CESSATECH A/S DK -20
F:8GN |
$38.17 Million | €37.18 Million | Germany | €2.21 | +2.08% | +6.27% | 2.71K |
| 862 |
NRXBF
OTCQB:NRXBF |
$37.98 Million | $37.98 Million | USA | $0.50 | +0.00% | +2.82% | 3.16K |
| 863 |
Eyenovia Inc
NASDAQ:EYEN |
$37.75 Million | $37.75 Million | USA | $14.36 | -9.23% | +50.37% | 208.56 Million |
| 864 |
Fluoguide AS
ST:FLUO |
$37.74 Million | Skr423.37 Million | Sweden | Skr34.50 | -4.43% | +5.18% | 185.48K |
| 865 |
ENTERA BIO IS-0000769
F:5DT |
$37.56 Million | €36.59 Million | Germany | €1.17 | +3.74% | +6.00% | 7.75K |
| 866 |
Vaccibody AS
F:5VB |
$37.47 Million | €36.50 Million | Germany | €0.23 | +1.97% | -6.01% | 31.45K |
| 867 |
RTA Laboratuvarlari Biyolojik
IS:RTALB |
$37.31 Million | TL1.32 Billion | Turkey | TL3.78 | -0.53% | -3.82% | 863.02 Million |
| 868 |
Genomics BioSci & Tech. Co.Ltd.
TWO:4195 |
$37.09 Million | NT$1.23 Billion | Taiwan | NT$23.45 | -3.30% | -2.70% | 4.40 Million |
| 869 |
Xilio Development Inc
NASDAQ:XLO |
$36.86 Million | $36.86 Million | USA | $7.60 | +2.29% | +1257.14% | 9.88 Million |
| 870 |
PharmAust Ltd
F:ECQ |
$36.79 Million | €35.84 Million | Germany | €0.10 | +0.00% | +0.00% | 0.00 |
| 871 |
Veru Inc
NASDAQ:VERU |
$36.76 Million | $36.76 Million | USA | $2.30 | -4.56% | -6.88% | 1.37 Million |
| 872 |
ImmuCell Corporation
NASDAQ:ICCC |
$36.34 Million | $36.34 Million | USA | $6.04 | -0.17% | -8.90% | 291.13K |
| 873 |
HeXun Biosciences Co., Ltd.
TWO:6986 |
$36.22 Million | NT$1.20 Billion | Taiwan | NT$58.70 | +6.92% | +10.34% | 1.35 Million |
| 874 |
Take Solutions Limited
NSE:TAKE |
$35.96 Million | ₹3.11 Billion | India | ₹39.68 | -1.98% | +4.83% | 18.34 Million |
| 875 |
Nyrada Inc
AU:NYR |
$35.92 Million | AU$58.01 Million | Australia | AU$0.54 | +0.94% | -1.83% | 16.18 Million |
| 876 |
Atossa Genetics Inc
NASDAQ:ATOS |
$35.74 Million | $35.74 Million | USA | $5.11 | -6.92% | +6.90% | 2.13 Million |
| 877 |
Lipocine Inc
NASDAQ:LPCN |
$35.73 Million | $35.73 Million | USA | $7.30 | -4.82% | -9.99% | 2.69 Million |
| 878 |
Inter Pharma Public Company Limited
BK:IP |
$35.71 Million | ฿1.24 Billion | Thailand | ฿4.26 | +0.95% | +9.23% | 11.05 Million |
| 879 |
BIOMED-LUBLIN WYT.SUR.
F:6NQ |
$35.57 Million | €34.66 Million | Germany | €0.91 | +6.32% | +7.97% | 0.00 |
| 880 |
Synthaverse S.A.
WAR:SVE |
$35.52 Million | zł147.71 Million | Poland | zł3.87 | -1.02% | +4.88% | 909.42K |
| 881 |
Lisata Therapeutics Inc.
NASDAQ:LSTA |
$35.39 Million | $35.39 Million | USA | $5.01 | -0.40% | -0.40% | 1.87 Million |
| 882 |
FLUOGUIDE A/S DK -1
F:96X |
$35.27 Million | €34.36 Million | Germany | €2.80 | +0.00% | -3.45% | 1.00K |
| 883 |
Nykode Therapeutics AS
PINK:VACBF |
$35.04 Million | $35.04 Million | USA | $0.22 | +0.00% | +0.00% | 0.00 |
| 884 |
Sernova Biotherapeutics Inc
XETRA:PSH0 |
$34.83 Million | €33.93 Million | Germany | €0.11 | +5.00% | -7.08% | 732.17K |
| 885 |
Kezar Life Sciences Inc
NASDAQ:KZR |
$34.80 Million | $34.80 Million | USA | $6.81 | +0.00% | -4.49% | 851.74K |
| 886 |
Connect Biopharma Holdings Ltd
NASDAQ:CNTB |
$34.73 Million | $34.73 Million | USA | $2.72 | +0.37% | -2.51% | 2.65 Million |
| 887 |
Werewolf Therapeutics Inc
NASDAQ:HOWL |
$34.72 Million | $34.72 Million | USA | $0.84 | -3.11% | +13.93% | 10.98 Million |
| 888 |
Sernova Corp
OTCQB:SEOVF |
$34.31 Million | $34.31 Million | USA | $0.13 | -0.70% | +16.45% | 416.46K |
| 889 |
Gemina Laboratories Ltd
OTCQB:GLABF |
$34.29 Million | $34.29 Million | USA | $0.79 | +0.00% | -10.76% | 87.88K |
| 890 |
CHA Vaccine Institute Co. Ltd.
KQ:261780 |
$34.19 Million | ₩50.06 Billion | Korea | ₩3145.00 | +0.16% | +10.93% | 4.85 Million |
| 891 |
Prostemics Co. Ltd
KQ:203690 |
$34.15 Million | ₩50.00 Billion | Korea | ₩4425.00 | +0.00% | +0.00% | 62.86K |
| 892 |
Great Novel Therapeutics Biotech & Medicals
TWO:7427 |
$34.01 Million | NT$1.13 Billion | Taiwan | NT$31.40 | -1.10% | -5.28% | 5.80 Million |
| 893 |
Actinium Pharmaceuticals Inc
NYSE MKT:ATNM |
$33.94 Million | $33.94 Million | USA | $1.10 | -3.51% | -9.09% | 2.61 Million |
| 894 |
eXoZymes, Inc.
NASDAQ:EXOZ |
$33.94 Million | $33.94 Million | USA | $7.13 | -2.46% | -2.33% | 68.86K |
| 895 |
Herantis Pharma Oyj
HE:HRTIS |
$33.78 Million | €32.91 Million | Finland | €1.89 | +0.53% | -3.08% | 751.08K |
| 896 |
Shine-On BioMedical Co.,Ltd.
TWO:6926 |
$33.58 Million | NT$1.11 Billion | Taiwan | NT$66.90 | +0.90% | -2.90% | 496.99K |
| 897 |
RenovoRx Inc
NASDAQ:RNXT |
$33.49 Million | $33.49 Million | USA | $1.03 | +6.59% | +25.61% | 7.15 Million |
| 898 |
B1Q
F:B1Q |
$33.40 Million | €32.53 Million | Germany | €1.57 | -7.10% | +3.29% | 25.38K |
| 899 |
Abnova Taiwan Corp
TW:4133 |
$33.33 Million | NT$1.10 Billion | Taiwan | NT$23.30 | +0.43% | -0.21% | 4.61 Million |
| 900 |
FibroGen Inc
NASDAQ:FGEN |
$33.04 Million | $33.04 Million | USA | $9.22 | -5.05% | +5.98% | 925.11K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries